about
Propargyl-Linked Antifolates Are Potent Inhibitors of Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosisLow-Dose Systemic Methotrexate Therapy for Recalcitrant Alopecia Areata.Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study.Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centersAdvances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets?A systemic review and meta-analysis of the clinical efficacy and safety of total glucosides of peony combined with methotrexate in rheumatoid arthritis.Characteristics and Long-Term Outcome of Neurosarcoidosis: A Population-Based Study from 1976-2013.Inadequate response or intolerability to oral methotrexate: Is it optimal to switch to subcutaneous methotrexate prior to considering therapy with biologics?Methotrexate in crohn's disease: a new face for an old drug?Probiotic bacteria: a viable adjuvant therapy for relieving symptoms of rheumatoid arthritis.Hydrophobic ion pairing as a strategy to improve drug encapsulation into lipid nanocarriers for the cancer treatment.Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study.Vildagliptin-induced acute lung injury: a case report.H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome.Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients.Biologic drugs in adult onset Still's disease: a systematic review and meta-analysis of observational studies.Emerging treatment options for the management of pemphigus vulgaris.Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate
P2860
Q28553792-76F436DE-5D2D-44CB-8209-78D63D3C8DC8Q33710614-77FC19D7-537A-4C3A-A8C6-F85D84C9F52AQ33898530-16A80807-E959-4082-BA9F-7B83D9A3EDCAQ36208563-12C33555-519E-4BA1-8C08-3DE25BA0FEEBQ38637780-7B47E592-2E41-48E2-939B-D226C89B8A1CQ38658407-7D81BCB0-DEA8-4038-BAE4-CFC097DDAD71Q38732080-4C78D5CD-FA48-423A-BF49-75D2D125EF9DQ38758521-8CAF4FD5-9688-4CB4-89D0-68DC60FA6CF2Q38826428-FED29493-C265-4576-8C80-80C8D343F188Q38942815-5268BF8F-8ECC-44AF-B4D3-87B38EDA9159Q39021928-37016FA6-E39C-4CEC-9D26-DE34DDFC05A8Q40073352-76D2DDBD-390E-4E2A-A3C9-7876DADB1139Q40577527-B2C73A46-22B7-43E9-B430-E517BD8CA30BQ47727637-F01EA44B-00A0-4C3D-90EA-E62AA5D14FC5Q48340351-3DCE856C-E428-4A5B-9CD8-51740C58F2B6Q50224636-6E75D624-D788-4C40-9AE9-4089FA09DF9AQ55433740-ED8593A1-7C91-4559-BD01-0BA1B6B02437Q59135667-D4A59954-DB70-47B7-8965-B8C97B0B61EE
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Methotrexate: an old new drug in autoimmune disease.
@en
type
label
Methotrexate: an old new drug in autoimmune disease.
@en
prefLabel
Methotrexate: an old new drug in autoimmune disease.
@en
P2860
P50
P1476
Methotrexate: an old new drug in autoimmune disease
@en
P2093
Francesco Carubbi
Piero Ruscitti
P2860
P304
P356
10.1586/1744666X.2014.962996
P577
2014-09-22T00:00:00Z